胸腺组成预测肺癌治疗中的肺炎风险
medRxiv : the preprint server for health sciences
|November 24, 2025
概括
剩余的胸膜组织 (pTT) 预测了在不能切除的第三阶段非小细胞肺癌 (NSCLC) 患者的肺炎风险,这些患者接受化学放射治疗和杜尔瓦卢马布治疗. 较低的pTT表明风险更高,有助于个性化治疗策略.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 免疫治疗是一种免疫疗法.
背景情况:
- 化学放射治疗 (cCRT) 后的杜尔瓦卢马布是不可切除的III期NSCLC的标准.
- 肺炎是一种常见的毒性限制免疫治疗.
- 目前肺炎的预测因素缺乏个人歧视.
研究的目的:
- 为了研究胸腺在治疗后免疫恢复和炎症毒性中的作用.
- 评估胸膜组织比例 (pTT) 是否预测肺炎风险.
主要方法:
- 分析了来自RTOG 0617 (n=490) 和MSKCC (n=230) 队列的NSCLC患者.
- 使用CT成像进行量化治疗前百分比的胸膜组织 (pTT).
- 使用后勤回归来将pTT,肺V20和MDTR与高级肺炎联系起来.
主要成果:
- 在两个队列中,pTT独立地与较低的严重肺炎风险有关.
- 低pTT与高肺V20相结合,确定了患有肺炎风险最高的患者.
- MDTR显示出与肺炎的较弱,非线性关联.
结论:
- 百分比胸膜组织 (pTT) 是一种新的,严重肺炎的独立预测器.
- pTT可以改善接受cCRT和免疫治疗的患者的风险分层.
- 结合pTT可以个性化辐射规划并提高治疗安全性.
更多相关视频
09:02Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
14.2K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
相关概念视频
01:17Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K